Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Ortho-Clinical Diagnostics, Inc. Company Profile

11:19 EDT 23rd April 2014 | BioPortfolio

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. For more information, visit www.orthoclinical.com.


News Articles [965 Associated News Articles listed on BioPortfolio]

Johnson & Johnson’s to Sell Ortho-Clinical Diagnostics Business for $4.15B

The Carlyle Group has agreed to acquire Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business, a global provider of solutions for screening, diagnosing, monitoring and confirming disease...

Carlyle Group makes binding offer to acquire J&J’s Ortho-Clinical Diagnostics

Johnson & Johnson has received a binding offer from the Carlyle Group to acquire its Ortho-Clinical Diagnostics business for $4.15 billion. Ortho-Clinical Diagnostics delivers in vitro diagnostic prod...

Carlyle Group in business merger for J&J’s ortho clinical diagnostics unit

Carlyle Group is nearing an agreement to acquire Johnson & Johnson’s ortho clinical diagnostics unit, in a deal expected to be worth around $4 billion. J&J’s ortho clinical diagnos...

Was Selling Ortho-Clinical Diagnostics A Right Move For Johnson & Johnson?

By Trefis: Johnson & Johnson's (JNJ) image is undergoing a transformation as its pharmaceuticals business is becoming more significant. The company has traditionally been known for its medical de...

J&J gets $4.2B offer for Ortho-Clinical Diagnostics business

Johnson & Johnson (NYSE:JNJ) received a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion. The business markets products t...

Johnson & Johnson accepts $4 billion offer for Ortho-Clinical Diagnostics

US health care giant Johnson & Johnson revealed yesterday that it has accepted the binding offer from The Carlyle Group, which was received and announced on January 16, 2014, to acquire its Ortho-Clin...

Carlyle Group offers $4.15bn for J&J's Ortho-Clinical Diagnostics

A year after Johnson & Johnson said it was contemplating the sale or possible spin-off of its Ortho-Clinical Diagnostics Inc. (OCD) division, Carlyle Group agreed to buy it for $4.15bn.

Carlyle agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15bn

Global alternative asset manager The Carlyle Group has agreed to acquire Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business for $4.15bn.

PubMed Articles [1596 Associated PubMed Articles listed on BioPortfolio]

Integrating molecular diagnostics into histopathology training: the Belfast model.

Molecular medicine is transforming modern clinical practice, from diagnostics to therapeutics. Discoveries in research are being incorporated into the clinical setting with increasing rapidity. This t...

Fungal diagnostics.

Early diagnosis of fungal infection is critical to effective treatment. There are many impediments to diagnosis such as a diminishing number of clinical mycologists, cost, time to result, and requirem...

Ruthenium-Catalyzed Cross-Dehydrogenative ortho-N-Carbazolation of Diarylamines: Versatile Access to Unsymmetrical Diamines.

The dehydrogenative C-N cross-coupling of unprotected, secondary anilines through ortho-N-carbazolation has been achieved using a Ru catalytic system with O2 as the terminal oxidant. The reactions pro...

Point-of-Care Diagnostics in Low-Resource Settings and Their Impact on Care in the Age of the Noncommunicable and Chronic Disease Epidemic.

The emergence of point-of-care (POC) diagnostics specifically designed for low-resource settings coupled with the rapid increase in need for routine care of patients with chronic diseases should promp...

Dihydrobiphenylenes through Ruthenium-Catalyzed 2+2+2 Cycloadditions of ortho-Alkenylarylacetylenes with Alkynes.

A new synthetic route to dihydrobiphenylenes has been developed. The process involves a mild Ru(II) -catalyzed [2+2+2] dimerization of ortho-alkenylarylacetylenes or its more versatile variant, the Ru...

Clinical Trials [914 Associated Clinical Trials listed on BioPortfolio]

To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50 years of...

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

The purpose of this study is to assess the effect of BMS-790052 on the pharmacokinetics of Ortho Tri-Cyclen® in healthy female subjects.

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Topiramate (2 x 25 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Topamax®, Ortho-McNeil Neurologics, Inc.) in Fed, Healthy, Adult Subjects

- Objective: - Compare the bioequivalence of a test topiramate formulation (Torrent Pharmaceuticals Limited) to an equivalent oral dose of the commercially available...

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

The purpose of this study is to administer a combined oral contraceptive (ethinyl estradiol and norgestimate) with the HIV treatment of atazanavir and ritonavir to healthy females in order...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of...

Companies [2083 Associated Companies listed on BioPortfolio]

Ortho-Clinical Diagnostics, Inc.

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to mak...

Ortho Clinical Diagnostics

Ortho Women's Health & Urology(TM)

Ortho Women's Health & Urology(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a leader in the fields of women's health and urology, celebrating more than 75 years of partnering with w...

Ortho Kinematics

Ortho Kinematics is a privately held spine diagnostics enterprise committed to the idea that spine motion matters. The company is working with a group of leading clinicians, resea...

Ortho Biotech Incorporated

Ortho Biotech Inc. is a member of the Johnson & Johnson family of companies. As a company engaged in the business of innovative research, Ortho Biotech is pleased to share with professionals and patie...

More Information about "Ortho-Clinical Diagnostics, Inc." on BioPortfolio

We have published hundreds of Ortho-Clinical Diagnostics, Inc. news stories on BioPortfolio along with dozens of Ortho-Clinical Diagnostics, Inc. Clinical Trials and PubMed Articles about Ortho-Clinical Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ortho-Clinical Diagnostics, Inc. Companies in our database. You can also find out about relevant Ortho-Clinical Diagnostics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement